St Eloi University Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2014
NCT02276690
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Biochemistry and clinical proteomic laboratory, IRMB, St Eloi University Hospital

Active Ingredients

Drugs in Other Trials (3)

ferritin (1 trial)

ly2787106 (1 trial)

transferrin (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 3